293 related articles for article (PubMed ID: 29361415)
1. The association between erythromycin monotherapy for Mycobacterium avium complex lung disease and cross-resistance to clarithromycin: A retrospective case-series study.
Hosono Y; Kitada S; Yano Y; Mori M; Miki K; Miki M; Yoshimura K; Kagawa H; Oshitani Y; Yokota S
J Infect Chemother; 2018 May; 24(5):353-357. PubMed ID: 29361415
[TBL] [Abstract][Full Text] [Related]
2. Long-term, low-dose erythromycin monotherapy for Mycobacterium avium complex lung disease: a propensity score analysis.
Komiya K; Kurashima A; Ihi T; Nagai H; Matsumoto N; Mizunoe S; Ishii H; Takahashi O; Ohta K; Kudoh S; Kadota J
Int J Antimicrob Agents; 2014 Aug; 44(2):131-5. PubMed ID: 24948577
[TBL] [Abstract][Full Text] [Related]
3. Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease.
Kadota T; Matsui H; Hirose T; Suzuki J; Saito M; Akaba T; Kobayashi K; Akashi S; Kawashima M; Tamura A; Nagai H; Akagawa S; Kobayashi N; Ohta K
BMC Infect Dis; 2016 Jan; 16():31. PubMed ID: 26818764
[TBL] [Abstract][Full Text] [Related]
4. [Clinical features and treatment history of clarithromycin resistance in M. avium-intracellulare complex pulmonary disease patients].
Kuwabara K; Tsuchiya T
Nihon Kokyuki Gakkai Zasshi; 2007 Aug; 45(8):587-92. PubMed ID: 17763685
[TBL] [Abstract][Full Text] [Related]
5. A Rapid Screening Assay for Clarithromycin-Resistant Mycobacterium avium Complex Using Melting Curve Analysis with Nonfluorescent Labeled Probes.
Aoki A; Jinno H; Ogawa K; Nakagawa T; Inagaki T; Wajima T; Okamoto Y; Uchiya KI
Microbiol Spectr; 2023 Feb; 11(1):e0432622. PubMed ID: 36622171
[TBL] [Abstract][Full Text] [Related]
6. Effective treatment for clarithromycin-resistant Mycobacterium avium complex lung disease.
Adachi Y; Tsuyuguchi K; Kobayashi T; Kurahara Y; Yoshida S; Kagawa T; Hayashi S; Suzuki K
J Infect Chemother; 2020 Jul; 26(7):676-680. PubMed ID: 32171660
[TBL] [Abstract][Full Text] [Related]
7. Difference in drug susceptibility distribution and clinical characteristics between
Wang W; Yang J; Wu X; Wan B; Wang H; Yu F; Guo Y
J Med Microbiol; 2021 May; 70(5):. PubMed ID: 33999797
[No Abstract] [Full Text] [Related]
8. Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease.
Griffith DE; Brown-Elliott BA; Langsjoen B; Zhang Y; Pan X; Girard W; Nelson K; Caccitolo J; Alvarez J; Shepherd S; Wilson R; Graviss EA; Wallace RJ
Am J Respir Crit Care Med; 2006 Oct; 174(8):928-34. PubMed ID: 16858014
[TBL] [Abstract][Full Text] [Related]
9. Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates.
Kobashi Y; Yoshida K; Miyashita N; Niki Y; Oka M
J Infect Chemother; 2006 Aug; 12(4):195-202. PubMed ID: 16944258
[TBL] [Abstract][Full Text] [Related]
10. Acquired resistance in Mycobacterium avium complex strains isolated from AIDS patients and beige mice during treatment with clarithromycin.
Doucet-Populaire F; Truffot-Pernot C; Grosset J; Jarlier V
J Antimicrob Chemother; 1995 Jul; 36(1):129-36. PubMed ID: 8537260
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic drug monitoring in the treatment of Mycobacterium avium complex lung disease.
Koh WJ; Jeong BH; Jeon K; Lee SY; Shin SJ
Am J Respir Crit Care Med; 2012 Oct; 186(8):797-802. PubMed ID: 22878282
[TBL] [Abstract][Full Text] [Related]
12. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease.
Ye JJ; Wu TS; Chiang PC; Lee MH
J Microbiol Immunol Infect; 2007 Aug; 40(4):342-8. PubMed ID: 17712469
[TBL] [Abstract][Full Text] [Related]
13. Macrolide/Azalide therapy for nodular/bronchiectatic mycobacterium avium complex lung disease.
Wallace RJ; Brown-Elliott BA; McNulty S; Philley JV; Killingley J; Wilson RW; York DS; Shepherd S; Griffith DE
Chest; 2014 Aug; 146(2):276-282. PubMed ID: 24457542
[TBL] [Abstract][Full Text] [Related]
14. PCR-Based Rapid Identification System Using Bridged Nucleic Acids for Detection of Clarithromycin-Resistant Mycobacterium avium-M. intracellulare Complex Isolates.
Hirama T; Shiono A; Egashira H; Kishi E; Hagiwara K; Nakamura H; Kanazawa M; Nagata M
J Clin Microbiol; 2016 Mar; 54(3):699-704. PubMed ID: 26739154
[TBL] [Abstract][Full Text] [Related]
15. Minimum inhibitory concentrations of azithromycin in clinical isolates of
Uwamino Y; Aoki W; Inose R; Kamoshita Y; Mikita K; Namkoong H; Nishimura T; Matsushita H; Hasegawa N
Microbiol Spectr; 2024 Jun; 12(6):e0021824. PubMed ID: 38687080
[TBL] [Abstract][Full Text] [Related]
16. Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease.
Wallace RJ; Brown BA; Griffith DE; Girard WM; Murphy DT; Onyi GO; Steingrube VA; Mazurek GH
Am J Respir Crit Care Med; 1994 May; 149(5):1335-41. PubMed ID: 8173775
[TBL] [Abstract][Full Text] [Related]
17. Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens.
Cho EH; Huh HJ; Song DJ; Moon SM; Lee SH; Shin SY; Kim CK; Ki CS; Koh WJ; Lee NY
J Infect Chemother; 2018 Apr; 24(4):315-318. PubMed ID: 29223615
[TBL] [Abstract][Full Text] [Related]
18. Clarithromycin-resistant mycobacterium avium is still susceptible to treatment with clarithromycin and is virulent in mice.
Bermudez LE; Nash K; Petrofsky M; Young LS; Inderlied CB
Antimicrob Agents Chemother; 2000 Oct; 44(10):2619-22. PubMed ID: 10991834
[TBL] [Abstract][Full Text] [Related]
19. A survey of clarithromycin monotherapy and long-term administration of ethambutol for patients with MAC lung disease in Japan: A retrospective cohort study using the database of health insurance claims.
Iwao T; Kato G; Ito I; Aramaki E; Kuroda T
Pharmacoepidemiol Drug Saf; 2020 Apr; 29(4):427-432. PubMed ID: 31876044
[TBL] [Abstract][Full Text] [Related]
20. Presence of macrolide resistance in respiratory flora of HIV-Infected patients receiving either clarithromycin or azithromycin for Mycobacterium avium complex prophylaxis.
Aberg JA; Wong MK; Flamm R; Notario GF; Jacobson MA
HIV Clin Trials; 2001; 2(6):453-9. PubMed ID: 11742432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
